World Journal of Clinical Cases - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Ochani RK, Shaikh A, Batra S, Pikale G, Surani S. Diabetes among Muslims during Ramadan: A narrative review. World J Clin Cases 2023; 11(26): 6031-6039 [PMID: 37731557 DOI: 10.12998/wjcc.v11.i26.6031]
URL:	https://www.wjgnet.com/2307-8960/full/v11/i26/6031.htm

(175) (175) (0) (0) (0) (11) (4) (1) (14392) (14)

Number	Citing Articles
1	Ioannis Ilias, Athanasios Tselebis. Do not forget diet and exercise during Ramadan. World Journal of Clinical Cases 2023; 11(31): 7738-7740 doi: 10.12998/wjcc.v11.i31.7738 Abstract(988) \| Core Tip(756) \| Full Article(HTML)(1594) \| Full Article (PDF)-325K(184) \| Full Article with Cover (PDF)-591K(170) \| Full Article (Word)-105K(42) \| Full Article (XML)-17K(133) \| Audio-435K(16) \| Peer-Review Report-217K(135) \| Answering Reviewers-59K(151) \| Times Cited (1) \| Total Visits (2733) \| Open
2	Bachar Afandi, Mohammed Hassanein, Mohamed Suliman, Khadija Hafidh. Personalized risk reduction strategies utilizing the diabetes and ramadan risk calculator: a narrative review. Journal of Diabetes & Metabolic Disorders 2024; 24(1) doi: 10.1007/s40200-024-01506-3
3	A.A. Arie Widyastuti, Nurul H. Muchtar, Jerry Nasarudin, M. Ikhsan Mokoagow, Marina Epriliawati, Ika Saptarini, Ida A. Made Kshanti. Improving knowledge on the management of diabetes mellitus during Ramadan. Journal of Taibah University Medical Sciences 2025; 20(6) doi: 10.1016/j.jtumed.2025.10.005
4	Elamin Abdelgadir, Mohamed Hassanein, Salem Beshyah, Bachar Afandi, Fauzia Rashid, Alaaeldin Bashir, Khadija Hafidh, Fatheya Alawadi. Meta-analysis on the validity and clinical utility of the IDF/DAR risk stratification tool. Diabetes Research and Clinical Practice 2025; 230 doi: 10.1016/j.diabres.2025.112994
5	Mahmoud Ibrahim, Ebtesam M. Ba‐Essa, Asma Ahmed, Ehtasham Ahmad, Firas A. Annabi, Hanene Chaabane, Dario Tuccinardi, Melanie J. Davies, Francesco De Domenico, Robert H. Eckel, Nancy Elbarbary, Pamela Houeiss, Silvia Manfrini, Shabeen Naz Masood, Omar Mobarak, Shehla Shaikh, Safia Mimouni‐Zerguini, Guillermo E. Umpierrez. Recommendations for the Management of Diabetes During Ramadan Applying the Principles of the ADA/ EASD Consensus: Update 2025. Diabetes/Metabolism Research and Reviews 2025; 41(5) doi: 10.1002/dmrr.70057
6	Prolonged Fasting: Scoping Review with ☸️SAIMSARA. SAIMSARA Journal 2026; 1(2) doi: 10.62487/saimsara93074bf6
7	Ayman Al Hayek, Wael M. Al Zahrani, Mohammed A. Al Dawish. Implications of the Glycemia Risk Index in Assessing Metabolic Control and its Correlation With Therapy-Related Quality of Life During-Ramadan Fasting in Adults With Type 2 Diabetes. Journal of Diabetes Science and Technology 2025; doi: 10.1177/19322968251321860
8	Bachar Afandi, Juma Al kaabi, Charu Sharma. Impact of Twice-Weekly Islamic Fasting on Cardiovascular Risk Factors in Women with Type 2 Diabetes Mellitus. Journal of Diabetes and Endocrine Practice 2025; 8(03) doi: 10.1055/s-0045-1806834
9	Ashokkumar Thirunavukkarasu, Aseel Awad Alsaidan. Self-Management Behaviours in Type 2 Diabetes Across Gulf Cooperation Council Countries: An Updated Narrative Review to Enhance Patient Care. Healthcare 2025; 13(17) doi: 10.3390/healthcare13172247
10	Mohamed Hassanein, Bachar Afandi, Salem A. Beshyah. The DAR Survey of Physicians' Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors during Ramadan. Journal of Diabetes and Endocrine Practice 2025; doi: 10.1055/s-0045-1811584
11	Mohammed Abdulrasak, Nael Shaat, Ali M. Someili, Mostafa Mohrag. Unmasking Gastroparesis in Diabetes During Ramadan: Challenges and Management Strategies. Journal of Clinical Medicine 2025; 14(6) doi: 10.3390/jcm14061997
12	Abul Bashar Mohammad Kamrul-Hasan, Joseph M Pappachan, Hamid Ashraf, Lakshmi Nagendra, Deep Dutta, Mohammad Shafi Kuchay, Shehla Shaikh. Safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with type 2 diabetes mellitus fasting during Ramadan: a systematic review and meta-analysis. World Journal of Methodology 2025; 15(4): 105478 doi: 10.5662/wjm.v15.i4.105478 Abstract(319) \| Core Tip(284) \| Full Article(HTML)(4409) \| Full Article (PDF)-1372K(315) \| Full Article with Cover (PDF)-1702K(150) \| Full Article (XML)-115K(57) \| Audio-1546K(28) \| Peer-Review Report-454K(51) \| Answering Reviewers-77K(54) \| Supplementary Material-249K(56) \| Times Cited (0) \| Total Visits (5452) \| Open
13	Sanobia Yousuf, Muhammad Yakoob Ahmedani. Effectiveness and Safety of Once-Weekly Trelagliptin versus Daily DPP-4 Inhibitors in Fasting People with Type 2 Diabetes during Ramadan. Journal of Diabetes and Endocrine Practice 2026; doi: 10.1055/s-0046-1820424
14	Joseph M Pappachan, Deep Dutta, Lakshmi Nagendra, Mohammad Shafi Kuchay, Hamid Ashraf, Shehla Shaikh, Abul Bashar Mohammad Kamrul-Hasan. Safety and efficacy of sodium-glucose cotransporter-2 inhibitors in adults with type 2 diabetes fasting during Ramadan: A meta-analysis. World Journal of Diabetes 2026; 17(2): 115495 doi: 10.4239/wjd.v17.i2.115495 Abstract(43) \| Core Tip(35) \| Full Article(HTML)(251) \| Full Article (PDF)-4384K(51) \| Full Article with Cover (PDF)-4838K(182) \| Full Article (XML)-151K(24) \| Audio-1439K(13) \| Peer-Review Report-488K(23) \| Answering Reviewers-143K(46) \| Supplementary Material-262K(14) \| Times Cited (0) \| Total Visits (577) \| Open

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.